Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating and regulating adaptive immune responses. Upon activation by antigens and danger signals, DCs mature, upregulate MHC and co-stimulatory molecules, and migrate to lymph nodes to activate T cells. Enhanced antigen presentation by DCs is a key strategy in vaccine development and cancer immunotherapy to elicit robust T cell responses.
Drugs enhance antigen uptake, processing, and presentation by DCs, leading to increased T cell activation and immune response. Adjuvants stimulate DCs via pattern recognition receptors (PRRs) like TLRs, promoting maturation and cytokine release.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic Cells (Activated) (DCs (Activated)).